← Eichor
Study identifier: NCT05551104 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Safest Choice of Antihypertensive Regimen for Postpartum Hypertension

Condition: Postpartum Complication · Maternal Hypertension · High Blood Pressure  ·  Sponsor: Loma Linda University

PhasePhase 3
Planned participants500
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this investigator-initiated randomized control trial is to determine whether oral Nifedipine versus oral Labetalol is superior in controlling high blood pressures in the postpartum period.

This description comes directly from the study's public registry record.

Talk to the study team

Ashra Denise B Tugung, BSc  ·  9096515580  ·  atugung@llu.edu

Nikia Gray-Hutto, RN, CCRP  ·  9095584000  ·  nhutto@llu.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Loma Linda University HealthLoma Linda, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05551104